Outset Medical, Inc.
OM
$4.21
-$0.09-2.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -1.26% | 2.01% | 5.09% | 4.65% | 2.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.26% | 2.01% | 5.09% | 4.65% | 2.47% |
| Cost of Revenue | -9.44% | -5.43% | -2.74% | -5.10% | -8.86% |
| Gross Profit | 12.97% | 15.24% | 20.13% | 26.01% | 30.77% |
| SG&A Expenses | -1.46% | -8.60% | -17.31% | -22.48% | -26.38% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.61% | -10.60% | -16.40% | -20.37% | -24.70% |
| Operating Income | 14.85% | 26.49% | 38.81% | 43.64% | 46.51% |
| Income Before Tax | 24.77% | 34.70% | 36.51% | 37.87% | 38.55% |
| Income Tax Expenses | 135.77% | 84.68% | 46.23% | 1.98% | -22.31% |
| Earnings from Continuing Operations | 24.12% | 34.24% | 36.20% | 37.70% | 38.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.12% | 34.24% | 36.20% | 37.70% | 38.50% |
| EBIT | 14.85% | 26.49% | 38.81% | 43.64% | 46.51% |
| EBITDA | 13.26% | 26.21% | 39.62% | 45.02% | 48.03% |
| EPS Basic | 79.54% | 85.57% | 81.63% | 68.50% | 57.53% |
| Normalized Basic EPS | 78.09% | 84.89% | 84.11% | 70.95% | 59.31% |
| EPS Diluted | 79.54% | 85.57% | 81.63% | 68.50% | 57.53% |
| Normalized Diluted EPS | 78.09% | 84.89% | 84.11% | 70.95% | 59.31% |
| Average Basic Shares Outstanding | 128.41% | 309.90% | 335.93% | 236.71% | 134.91% |
| Average Diluted Shares Outstanding | 128.41% | 309.90% | 335.93% | 236.71% | 134.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |